Sirtuin-mediated modulation of cardiac fibrosis: Emerging molecular insights and therapeutic perspectives

Claudia Cozzolino1, Erica Floris1, Francesca Icolaro1

  • 1Department of Medical Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, Latina 04100, Italy.

Pharmacological Research
|September 26, 2025
PubMed

Insights

Sirtuins regulate cardiac fibrosis, with specific isoforms like SIRT1 and SIRT3 offering protective roles against heart failure. Targeting sirtuins presents a promising therapeutic strategy for mitigating fibrotic remodeling.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Pharmacology

Background:

  • Fibrosis is a key driver of heart failure progression, characterized by excessive extracellular matrix deposition.
  • The sirtuin family of NAD⁺-dependent deacetylases, known for roles in aging and metabolism, are emerging as critical regulators of cardiac fibrotic remodeling.

Purpose of the Study:

  • To review the multifaceted roles of sirtuins in mitigating cardiac fibrosis.
  • To explore the mechanisms by which sirtuins influence fibroblast activation and extracellular matrix production.
  • To assess the therapeutic potential of modulating sirtuin activity for treating heart failure.

Main Methods:

  • Literature review focusing on mechanistic insights and preclinical studies from the past three years.
  • Analysis of sirtuin isoform-specific effects on pro-fibrotic pathways, including the TGF-β/Smad pathway.
  • Examination of various therapeutic strategies targeting sirtuin activation.

Main Results:

  • Sirtuin signaling generally attenuates cardiac fibrosis by regulating fibroblast activation and collagen synthesis.
  • Specific isoforms (SIRT1, SIRT3, SIRT6, SIRT7) typically exert protective effects, while others (SIRT2, SIRT5) can be context-dependent.
  • Preclinical therapeutic strategies include NAD⁺ precursors, natural compounds, and specific small-molecule activators.

Conclusions:

  • Sirtuin modulation holds significant therapeutic potential for counteracting maladaptive cardiac remodeling in heart failure.
  • Understanding the isoform- and context-dependent actions of sirtuins is crucial for effective therapeutic development.
  • Pharmacological enhancement of sirtuin activity offers a promising avenue for anti-fibrotic therapy in cardiovascular disease.

Related Concept Videos